Wuhan Liyuan Hospital was founded in 1979, from that year, it began to carry out interventional therapy, and has 30 years of treatment history. In recent years, in order to adapt to the new form of development of interventional medicine, the hospital reintegrated medical resources and purchased Philips digital subtraction angiography equipment (DSA) with the international advanced level, and established the current interventional therapy center. Interventional therapy center is the key development department of the hospital, which is a large-scale comprehensive interventional diagnosis and treatment center integrating medical treatment, scientific research and teaching. It is also one of the departments in China that carries out comprehensive and full-featured interventional technology, with independent interventional ward, interventional operating room, interventional outpatient clinic and interventional training base.DSA Interventional Center adheres to the fine tradition of civilization and integrity, people-oriented, scientific management, deepening reform, and constantly forging ahead to continuously improve the quality of service and medical care, and make greater contributions to the cause of people's health promotion.
In the field of minimally invasive interventional diagnosis and treatment of various solid malignant tumors, benign tumors, peripheral vascular diseases, cerebrovascular diseases, hemorrhagic diseases, various non-vascular diseases, etc., the company has achieved very good results, especially in the fields of hepatocellular carcinoma, lung cancer, uterine fibroid tumors, arterial stenosis and embolism of upper and lower extremities, diabetic foot, esophageal stenosis, obstructive jaundice, cirrhosis of the liver, aseptic necrosis of femoral head, and stem cell transplantation, etc. The level of treatment is mostly at a high level. The treatment level of most of them is in the leading or advanced level in the country, such as transplantation. The annual operation volume is more than 2,000 times.